Abstract
Amniotic fluid embolism (AFE) is a rare and severe obstetric emergency and a significant cause of maternal mortality in developed countries and its incidence varies according to different studies. Presently, advances in the understanding of this pathology continue to be slowed down for the absence of generally accepted diagnostic criteria, the clinical analogies of this entity to other types of acute dangerous maternal illnesses and the presence of a wide range of disease severity. The aim of this review has been to evaluate the incidence of AFE, the role of possible risk factors, the clinical presentation (signs and symptoms) and outcome. Secondly the authors reviewed the management of these very difficult patients, including treatments and interventions in order to extrapolate sharable recommendations for the management of these complicated patients.
Keywords: Amniotic fluid embolism, incidence, risk factors, management and treatment, scientific evidence.
Current Pharmaceutical Biotechnology
Title:Amniotic Fluid Embolism: What Level of Scientific Evidence can be Drawn? A Systematic Review
Volume: 14 Issue: 14
Author(s): Paola Frati, Zeno Foldes-Papp, Simona Zaami and Francesco P. Busardo
Affiliation:
Keywords: Amniotic fluid embolism, incidence, risk factors, management and treatment, scientific evidence.
Abstract: Amniotic fluid embolism (AFE) is a rare and severe obstetric emergency and a significant cause of maternal mortality in developed countries and its incidence varies according to different studies. Presently, advances in the understanding of this pathology continue to be slowed down for the absence of generally accepted diagnostic criteria, the clinical analogies of this entity to other types of acute dangerous maternal illnesses and the presence of a wide range of disease severity. The aim of this review has been to evaluate the incidence of AFE, the role of possible risk factors, the clinical presentation (signs and symptoms) and outcome. Secondly the authors reviewed the management of these very difficult patients, including treatments and interventions in order to extrapolate sharable recommendations for the management of these complicated patients.
Export Options
About this article
Cite this article as:
Frati Paola, Foldes-Papp Zeno, Zaami Simona and Busardo P. Francesco, Amniotic Fluid Embolism: What Level of Scientific Evidence can be Drawn? A Systematic Review, Current Pharmaceutical Biotechnology 2013; 14 (14) . https://dx.doi.org/10.2174/1389201015666140430101639
DOI https://dx.doi.org/10.2174/1389201015666140430101639 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Seeds as a Production System for Molecular Pharming Applications: Status and Prospects
Current Pharmaceutical Design Differentiating Walking from other Activities of Daily Living in Older Adults Using Wrist-based Accelerometers
Current Aging Science Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry Perception of Symptoms in Hypertensive Patients and the Relevance to the Application of Anti- Hypertensive Drug Therapy
Current Pharmaceutical Design An Unusual Case of Reversible Empty Sella
Endocrine, Metabolic & Immune Disorders - Drug Targets Differentiating the Dementias. Revisiting Synucleinopathies and Tauopathies
Current Alzheimer Research Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Fish Oil Prevents Oxidative Stress and Exerts Sustained Antiamnesic Effect After Global Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Cutaneous Neurovascular Interaction Involved in Tactile Sensation
Cardiovascular & Hematological Agents in Medicinal Chemistry Mechanisms of Cardiovascular Changes in an Experimental Model of Syndrome X and Pharmacological Intervention on the Renin-Angiotensin- System
Current Vascular Pharmacology The Reno-Protective Effect of the Dual Blockade of the Renin Angiotensin System (RAS)
Current Pharmaceutical Design Chemical Constituents of Plants from the Genus Valeriana
Mini-Reviews in Organic Chemistry Antimicrobial Stewardship in the Neonatal Intensive Care Unit: An Update
Current Pediatric Reviews Therapeutic Interventions in the Glyc(oxid)ation Pathway
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Current Diabetes Reviews Pathophysiological Role of Proteasome-Dependent Proteolytic Pathway in Endothelin-1-Related Cardiovascular Diseases
Current Vascular Pharmacology Serum Zinc and β D Glucuronidase Enzyme Level in Type 2 Diabetes Mellitus with Periodontitis
Current Diabetes Reviews Synthesis of Biologically Active Catecholic Compounds via ortho-Selective Oxygenation of Phenolic Compounds Using Hypervalent Iodine(V) Reagents
Current Organic Synthesis Review of Rational Approaches to the Treatment of Pain Management-Role forOpioids Therapies
Current Drug Therapy Novel Hypotensive Agents from Verbesina Caracasana: Structure, Synthesis and Pharmacology
Current Medicinal Chemistry